(Reuters) - Barclays rose 0.5 percent and ABN 2.4 percent after their long-awaited announcement, but drugmaker AstraZeneca slipped 1.7 percent after unveiling a $15.2-billion acquisition of biotech group MedImmune.
In other M&A-related action, Scottish & Newcastle rose 2.5 percent on a report that Diageo and SABMiller had discussed breaking the British brewer up, and Societe Generale fell 2.8 percent after denying speculation of merger talks with UniCredit .
Read more at Reuters.com Hot Stocks News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment